Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control


Harper-Wynne, C.L., Sumpter, K., Ryan, C., Priest, K., Norton, A., Ross, P., Ford, H.E.R., Johnson, P. and O'Brien, M.E.R. (2005) Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control. Lung Cancer, 47, (2), 289-290. (doi:10.1016/j.lungcan.2004.08.013).

Download

Full text not available from this repository.

Item Type: Article
Additional Information: Letter to the Editor
ISSNs: 0169-5002 (print)
Related URLs:
Subjects: R Medicine > RM Therapeutics. Pharmacology
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: University Structure - Pre August 2011 > School of Medicine > Cancer Sciences
Item ID: 26360
Date Deposited: 10 Apr 2006
Last Modified: 01 Jun 2011 08:50
Contributors: Harper-Wynne, C.L. (Author)
Sumpter, K. (Author)
Ryan, C. (Author)
Priest, K. (Author)
Norton, A. (Author)
Ross, P. (Author)
Ford, H.E.R. (Author)
Johnson, P. (Author)
O'Brien, M.E.R. (Author)
Date: 2005
Additional Information: Letter to the Editor
Status: Published
Contact Email Address: mary.obrien@rmh.nthames.nhs.uk
URI: http://eprints.soton.ac.uk/id/eprint/26360

Actions (login required)

View Item View Item